Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Early Action for Prevention, Management of NAFLD in Diabetes
-
- FDA Accepts Ocaliva NDA for NASH
- FDA Approves Xeljanz Extended Release Tablets for UC
- Looking Back at 2019’s Top 10, Peer Tested by You Edward V. Loftus Jr., MD
- Anal Cancer Incidence, Mortality Rise Sharply in US
- Complete Endoscopic Healing Linked With Better Crohn’s Outcomes
- Low-volume Bowel Prep Still Effective, but Better Tolerated
- Marijuana Use Linked With Decreased Constipation
- Ambient Light Could Improve End-of-day Adenoma Detection
-
- Andexxa Effective in GI Bleeds
- ‘Building Bridges’ Between PCPs, Liver Specialists for HCV Led to 100% Cure
- Combination Therapy Prevents HCV Infection in Non-viremic Organ Recipients
- Endoscopic Ultrasound Radiofrequency Ablation Demonstrates High Success for Pancreatic Tumors
- Gastroenterologist to Rheumatologists: Suspect IBD More Often
- Improving Frailty in Patients With Cirrhosis Listed for LT Reduces Mortality
- More Data Needed on Xeljanz, VTE Risk in UC
- Multidisciplinary Program Reduces GI Complications After Orthopedic Surgery
-
- Novel Machine Learning Model Effectively Predicts NASH
- Serrated Polyp Detection Rate Tied to Post-colonoscopy Cancer Risk
- VIDEO: Novel Therapy Safe, Effective in Acute, Severe Alcoholic Hepatitis
- VIDEO: Risk for NASH May Increase With Type 2 Diabetes
- 4 Things to Know About the Romaine Lettuce Outbreak
- US Life Expectancy Drops After Decades of Improvement